基于全细胞的药物输送:载体,装载策略和生物医学应用
Yi Kong1, Jinwen Chen1, Yangqian Luo2
1Department of Pharmacy, The First People's Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou 311200, PR China.
International journal of pharmaceutics
|November 22, 2025
概括
基于全细胞的药物递送利用细胞作为向治疗的载体. 这篇评论探讨了它们的特性,在癌症等疾病中的应用,以及未来的潜力.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 基于全细胞的药物递送利用完整的细胞作为复杂的载体.
- 这些系统提供了诸如固有的准,扩展循环和生物相容性等优势.
研究的目的:
- 提供基于全细胞的药物递送系统的全面审查.
- 讨论它们的生物特性,药物负载,遗传修饰和治疗应用.
主要方法:
- 对使用整个活细胞或死细胞作为药物载体的研究进行文献综述.
- 分析细胞载体特性,药物加载技术和基因工程策略.
- 检查在治疗炎症性疾病,癌症和其他疾病中的应用.
主要成果:
- 作为药物载体的整个细胞表现出固有的目标部位积累和长期循环.
- 各种药物加载策略和基因工程方法可以增强载体功能.
- 在治疗炎症性疾病和癌症方面表现出潜力.
结论:
- 基于全细胞的药物输送为向治疗提供了一个有前途的平台.
- 需要进一步的研究来应对挑战,并优化这些系统用于临床使用.
相关概念视频
Cellular Membranes and Drug Transport
1.4K
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
1.4K
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
1.5K
Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
1.5K
Carrier-Mediated Transport
1.0K
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.0K
Drug Delivery: Overview
705
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
705
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
5.7K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
5.7K
Bioavailability Enhancement: Drug Permeability Enhancement
176
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
176


